### WordPress - Web publishing software Copyright 2011-2019 by the contributors This program is free software; you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation; either version 2 of the License, or (at your option) any later version. This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the GNU General Public License for more details. You should have received a copy of the GNU General Public License along with this program; if not, write to the Free Software Foundation, Inc., 51 Franklin St, Fifth Floor, Boston, MA 02110-1301 USA This program incorporates work covered by the following copyright and permission notices: b2 is (c) 2001, 2002 Michel Valdrighi - m@tidakada.com - http://tidakada.com Wherever third party code has been used, credit has been given in the code's comments. b2 is released under the GPL and WordPress - Web publishing software Copyright 2003-2010 by the contributors WordPress is released under the GPL --- ### GNU GENERAL PUBLIC LICENSE Version 2, June 1991 Copyright (C) 1989, 1991 Free Software Foundation, Inc. 51 Franklin Street, Fifth Floor, Boston, MA 02110-1301, USA Everyone is permitted to copy and distribute verbatim copies of this license document, but changing it is not allowed. ### Preamble The licenses for most software are designed to take away your freedom to share and change it. By contrast, the GNU General Public License is intended to guarantee your freedom to share and change free software--to make sure the software is free for all its users. This General Public License applies to most of the Free Software Foundation's software and to any other program whose authors commit to using it. (Some other Free Software Foundation software is covered by the GNU Lesser General Public License instead.) You can apply it to your programs, too. When we speak of free software, we are referring to freedom, not price. Our General Public Licenses are designed to make sure that you have the freedom to distribute copies of free software (and charge for this service if you wish), that you receive source code or can get it if you want it, that you can change the software or use pieces of it in new free programs; and that you know you can do these things. To protect your rights, we need to make restrictions that forbid anyone to deny you these rights or to ask you to surrender the rights. These restrictions translate to certain responsibilities for you if you distribute copies of the software, or if you modify it. For example, if you distribute copies of such a program, whether gratis or for a fee, you must give the recipients all the rights that you have. You must make sure that they, too, receive or can get the source code. And you must show them these terms so they know their rights. We protect your rights with two steps: (1) copyright the software, and (2) offer you this license which gives you legal permission to copy, distribute and/or modify the software. Also, for each author's protection and ours, we want to make certain that everyone understands that there is no warranty for this free software. If the software is modified by someone else and passed on, we want its recipients to know that what they have is not the original, so that any problems introduced by others will not reflect on the original authors' reputations. Finally, any free program is threatened constantly by software patents. We wish to avoid the danger that redistributors of a free program will individually obtain patent licenses, in effect making the program proprietary. To prevent this, we have made it clear that any patent must be licensed for everyone's free use or not licensed at all. The precise terms and conditions for copying, distribution and modification follow. ### TERMS AND CONDITIONS FOR COPYING, DISTRIBUTION AND MODIFICATION **0.** This License applies to any program or other work which contains a notice placed by the copyright holder saying it may be distributed under the terms of this General Public License. The "Program", below, refers to any such program or work, and a "work based on the Program" means either the Program or any derivative work under copyright law: that is to say, a work containing the Program or a portion of it, either verbatim or with modifications and/or translated into another language. (Hereinafter, translation is included without limitation in the term "modification".) Each licensee is addressed as "you". Activities other than copying, distribution and modification are not covered by this License; they are outside its scope. The act of running the Program is not restricted, and the output from the Program is covered only if its contents constitute a work based on the Program (independent of having been made by running the Program). Whether that is true depends on what the Program does. **1.** You may copy and distribute verbatim copies of the Program's source code as you receive it, in any medium, provided that you conspicuously and appropriately publish on each copy an appropriate copyright notice and disclaimer of warranty; keep intact all the notices that refer to this License and to the absence of any warranty; and give any other recipients of the Program a copy of this License along with the Program. You may charge a fee for the physical act of transferring a copy, and you may at your option offer warranty protection in exchange for a fee. **2.** You may modify your copy or copies of the Program or any portion of it, thus forming a work based on the Program, and copy and distribute such modifications or work under the terms of Section 1 above, provided that you also meet all of these conditions: **a)** You must cause the modified files to carry prominent notices stating that you changed the files and the date of any change. **b)** You must cause any work that you distribute or publish, that in whole or in part contains or is derived from the Program or any part thereof, to be licensed as a whole at no charge to all third parties under the terms of this License. **c)** If the modified program normally reads commands interactively when run, you must cause it, when started running for such interactive use in the most ordinary way, to print or display an announcement including an appropriate copyright notice and a notice that there is no warranty (or else, saying that you provide a warranty) and that users may redistribute the program under these conditions, and telling the user how to view a copy of this License. (Exception: if the Program itself is interactive but does not normally print such an announcement, your work based on the Program is not required to print an announcement.) These requirements apply to the modified work as a whole. If identifiable sections of that work are not derived from the Program, and can be reasonably considered independent and separate works in themselves, then this License, and its terms, do not apply to those sections when you distribute them as separate works. But when you distribute the same sections as part of a whole which is a work based on the Program, the distribution of the whole must be on the terms of this License, whose permissions for other licensees extend to the entire whole, and thus to each and every part regardless of who wrote it. Thus, it is not the intent of this section to claim rights or contest your rights to work written entirely by you; rather, the intent is to exercise the right to control the distribution of derivative or collective works based on the Program. In addition, mere aggregation of another work not based on the Program with the Program (or with a work based on the Program) on a volume of a storage or distribution medium does not bring the other work under the scope of this License. **3.** You may copy and distribute the Program (or a work based on it, under Section 2) in object code or executable form under the terms of Sections 1 and 2 above provided that you also do one of the following: **a)** Accompany it with the complete corresponding machine-readable source code, which must be distributed under the terms of Sections 1 and 2 above on a medium customarily used for software interchange; or, **b)** Accompany it with a written offer, valid for at least three years, to give any third party, for a charge no more than your cost of physically performing source distribution, a complete machine-readable copy of the corresponding source code, to be distributed under the terms of Sections 1 and 2 above on a medium customarily used for software interchange; or, **c)** Accompany it with the information you received as to the offer to distribute corresponding source code. (This alternative is allowed only for noncommercial distribution and only if you received the program in object code or executable form with such an offer, in accord with Subsection b above.) The source code for a work means the preferred form of the work for making modifications to it. For an executable work, complete source code means all the source code for all modules it contains, plus any associated interface definition files, plus the scripts used to control compilation and installation of the executable. However, as a special exception, the source code distributed need not include anything that is normally distributed (in either source or binary form) with the major components (compiler, kernel, and so on) of the operating system on which the executable runs, unless that component itself accompanies the executable. If distribution of executable or object code is made by offering access to copy from a designated place, then offering equivalent access to copy the source code from the same place counts as distribution of the source code, even though third parties are not compelled to copy the source along with the object code. **4.** You may not copy, modify, sublicense, or distribute the Program except as expressly provided under this License. Any attempt otherwise to copy, modify, sublicense or distribute the Program is void, and will automatically terminate your rights under this License. However, parties who have received copies, or rights, from you under this License will not have their licenses terminated so long as such parties remain in full compliance. **5.** You are not required to accept this License, since you have not signed it. However, nothing else grants you permission to modify or distribute the Program or its derivative works. These actions are prohibited by law if you do not accept this License. Therefore, by modifying or distributing the Program (or any work based on the Program), you indicate your acceptance of this License to do so, and all its terms and conditions for copying, distributing or modifying the Program or works based on it. **6.** Each time you redistribute the Program (or any work based on the Program), the recipient automatically receives a license from the original licensor to copy, distribute or modify the Program subject to these terms and conditions. You may not impose any further restrictions on the recipients' exercise of the rights granted herein. You are not responsible for enforcing compliance by third parties to this License. **7.** If, as a consequence of a court judgment or allegation of patent infringement or for any other reason (not limited to patent issues), conditions are imposed on you (whether by court order, agreement or otherwise) that contradict the conditions of this License, they do not excuse you from the conditions of this License. If you cannot distribute so as to satisfy simultaneously your obligations under this License and any other pertinent obligations, then as a consequence you may not distribute the Program at all. For example, if a patent license would not permit royalty-free redistribution of the Program by all those who receive copies directly or indirectly through you, then the only way you could satisfy both it and this License would be to refrain entirely from distribution of the Program. If any portion of this section is held invalid or unenforceable under any particular circumstance, the balance of the section is intended to apply and the section as a whole is intended to apply in other circumstances. It is not the purpose of this section to induce you to infringe any patents or other property right claims or to contest validity of any such claims; this section has the sole purpose of protecting the integrity of the free software distribution system, which is implemented by public license practices. Many people have made generous contributions to the wide range of software distributed through that system in reliance on consistent application of that system; it is up to the author/donor to decide if he or she is willing to distribute software through any other system and a licensee cannot impose that choice. This section is intended to make thoroughly clear what is believed to be a consequence of the rest of this License. **8.** If the distribution and/or use of the Program is restricted in certain countries either by patents or by copyrighted interfaces, the original copyright holder who places the Program under this License may add an explicit geographical distribution limitation excluding those countries, so that distribution is permitted only in or among countries not thus excluded. In such case, this License incorporates the limitation as if written in the body of this License. **9.** The Free Software Foundation may publish revised and/or new versions of the General Public License from time to time. Such new versions will be similar in spirit to the present version, but may differ in detail to address new problems or concerns. Each version is given a distinguishing version number. If the Program specifies a version number of this License which applies to it and "any later version", you have the option of following the terms and conditions either of that version or of any later version published by the Free Software Foundation. If the Program does not specify a version number of this License, you may choose any version ever published by the Free Software Foundation. **10.** If you wish to incorporate parts of the Program into other free programs whose distribution conditions are different, write to the author to ask for permission. For software which is copyrighted by the Free Software Foundation, write to the Free Software Foundation; we sometimes make exceptions for this. Our decision will be guided by the two goals of preserving the free status of all derivatives of our free software and of promoting the sharing and reuse of software generally. **NO WARRANTY** **11.** BECAUSE THE PROGRAM IS LICENSED FREE OF CHARGE, THERE IS NO WARRANTY FOR THE PROGRAM, TO THE EXTENT PERMITTED BY APPLICABLE LAW. EXCEPT WHEN OTHERWISE STATED IN WRITING THE COPYRIGHT HOLDERS AND/OR OTHER PARTIES PROVIDE THE PROGRAM "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. THE ENTIRE RISK AS TO THE QUALITY AND PERFORMANCE OF THE PROGRAM IS WITH YOU. SHOULD THE PROGRAM PROVE DEFECTIVE, YOU ASSUME THE COST OF ALL NECESSARY SERVICING, REPAIR OR CORRECTION. **12.** IN NO EVENT UNLESS REQUIRED BY APPLICABLE LAW OR AGREED TO IN WRITING WILL ANY COPYRIGHT HOLDER, OR ANY OTHER PARTY WHO MAY MODIFY AND/OR REDISTRIBUTE THE PROGRAM AS PERMITTED ABOVE, BE LIABLE TO YOU FOR DAMAGES, INCLUDING ANY GENERAL, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF THE USE OR INABILITY TO USE THE PROGRAM (INCLUDING BUT NOT LIMITED TO LOSS OF DATA OR DATA BEING RENDERED INACCURATE OR LOSSES SUSTAINED BY YOU OR THIRD PARTIES OR A FAILURE OF THE PROGRAM TO OPERATE WITH ANY OTHER PROGRAMS), EVEN IF SUCH HOLDER OR OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. ### END OF TERMS AND CONDITIONS ### How to Apply These Terms to Your New Programs If you develop a new program, and you want it to be of the greatest possible use to the public, the best way to achieve this is to make it free software which everyone can redistribute and change under these terms. To do so, attach the following notices to the program. It is safest to attach them to the start of each source file to most effectively convey the exclusion of warranty; and each file should have at least the "copyright" line and a pointer to where the full notice is found. one line to give the program's name and an idea of what it does. Copyright (C) yyyy name of author This program is free software; you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation; either version 2 of the License, or (at your option) any later version. This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the GNU General Public License for more details. You should have received a copy of the GNU General Public License along with this program; if not, write to the Free Software Foundation, Inc., 51 Franklin Street, Fifth Floor, Boston, MA 02110-1301, USA. Also add information on how to contact you by electronic and paper mail. If the program is interactive, make it output a short notice like this when it starts in an interactive mode: Gnomovision version 69, Copyright (C) year name of author Gnomovision comes with ABSOLUTELY NO WARRANTY; for details type `show w'. This is free software, and you are welcome to redistribute it under certain conditions; type `show c' for details. The hypothetical commands \`show w' and \`show c' should show the appropriate parts of the General Public License. Of course, the commands you use may be called something other than \`show w' and \`show c'; they could even be mouse-clicks or menu items--whatever suits your program. You should also get your employer (if you work as a programmer) or your school, if any, to sign a "copyright disclaimer" for the program, if necessary. Here is a sample; alter the names: Yoyodyne, Inc., hereby disclaims all copyright interest in the program `Gnomovision' (which makes passes at compilers) written by James Hacker. signature of Ty Coon, 1 April 1989 Ty Coon, President of Vice This General Public License does not permit incorporating your program into proprietary programs. If your program is a subroutine library, you may consider it more useful to permit linking proprietary applications with the library. If this is what you want to do, use the [GNU Lesser General Public License](http://www.gnu.org/licenses/lgpl.html) instead of this License. Je genetika & Varno odzivnost za starejše odrasle? – iRemodel

Je genetika & Varno odzivnost za starejše odrasle?

Leave a Comment / r49ffktst6f7 / By

Spremenljivost genetike in odzivov ima ključno vlogo pri določanju, kako se starejši odzivajo na zdravila in zdravljenje, postavljajo vprašanja o varnosti in učinkovitosti.

Ko področje genetike napreduje, se njene aplikacije širijo v različne vidike zdravstvenega varstva, vključno s prilagojeno medicino. Posebno zanimivo področje je, kako genetske razlike vplivajo na odziv na zdravila, zlasti pri starejših odraslih. Ta demografska skupina pogosto doživlja bolj zapletena zdravstvena vprašanja in večjo verjetnost jemanja več zdravil, zaradi česar je razumevanje genske spremenljivosti ključno. Ta članek se podrobneje spoprijema s tem, ali sta genetika in spremenljivost odziva varna za starejše odrasle, preučuje prepletenosti personalizirane medicine, soočanja z izzivi ter potencialne koristi in tveganja.

Razumevanje genetike in spremenljivosti odziva

Genetska spremenljivost se nanaša na razlike v zaporedjih DNK med posamezniki. Te razlike lahko pomembno vplivajo na to, kako se oseba odziva na določena zdravila ali zdravljenje. Za starejše odrasle je razumevanje teh genetskih dejavnikov še posebej pomembno, saj so bolj dovzetne za neželene učinke zaradi fizioloških sprememb, povezanih s starostjo in polifarmacijo (uporaba več zdravil).

Farmakogenomika, študija, kako geni vplivajo na odziv osebe na zdravila, je v ospredju tega raziskovanja. Z analizo posameznikove genetske ličila lahko izvajalci zdravstvenih storitev napovedujejo verjetnost uspešnih rezultatov zdravljenja, potencialnih stranskih učinkov in optimalnih odmerkov. Cilj tega personaliziranega pristopa je izboljšati učinkovitost zdravljenja in hkrati zmanjšati tveganja.

Vpliv staranja na presnovo drog

S staranjem ljudi se njihova telesa doživljajo različne spremembe, ki lahko vplivajo na presnovo drog. Na primer, funkcije jeter in ledvic, ki so ključne za očistek drog, pogosto upadajo s starostjo. To lahko privede do dolgotrajne prisotnosti zdravil v telesu, kar poveča tveganje za škodljive učinke. Poleg tega lahko spremembe telesne sestave, kot sta povečana maščoba in zmanjšana vitka telesna masa, prav tako spremenijo porazdelitev zdravil.

Genetski dejavniki sestavljajo te spremembe, povezane s starostjo. Na primer, starejši odrasli z določenimi genetskimi različicami lahko presnavljajo zdravila prehitro ali prepočasi. Hiter metabolizem lahko povzroči subterapevtsko raven zdravil, medtem ko lahko počasen presnova povzroči kopičenje in toksičnost. Farmakogenomsko testiranje lahko pomaga prepoznati te genetske razlike, kar omogoča bolj prilagojene in varnejše režime zdravil.

Prilagojena medicina: ugodnosti in premisleki

Prilagojena medicina, ki jo vodijo genetske informacije, Lekarna Spletna ponuja več prednosti za starejše odrasle. Z poravnavo načrtov zdravljenja z genetskim profilom posameznika lahko zdravstveni izvajalci izboljšajo učinkovitost zdravil in zmanjšajo neželene učinke. Ta pristop je še posebej koristen za obvladovanje kroničnih stanj, ki so pogosta pri starejših odraslih, kot so srčno -žilne bolezni, diabetes in rak.

Na primer, Warfarin, pogosto predpisan antikoagulant, predstavlja pomembne izzive zaradi ozkega terapevtskega indeksa in spremenljivosti pri odzivu na bolnika. Genetsko testiranje za različice v genih, kot sta CYP2C9 in VKORC1. Podobne pristope je mogoče uporabiti za druga zdravila, kot so statini in antihipertenzivi, kar povečuje varnost in učinkovitost.

Vendar prilagojeno zdravilo ni brez izzivov. Stroški genetskega testiranja so lahko prepovedni, razlaga rezultatov pa je potrebna specializirana znanja. Poleg tega je treba skrbno upoštevati etične posledice genetskega testiranja, vključno z vprašanji zasebnosti in potencialno diskriminacijo. Informirano soglasje in jasna komunikacija med izvajalci zdravstvenih storitev in pacienti sta ključni sestavni deli tega procesa.

Tveganja in etični premisleki

Medtem ko so potencialne koristi uporabe genetike za vodenje zdravljenja pri starejših odraslih pomembne, obstajajo povezana tveganja in etični premisleki. Glavna skrb je potencial za genetsko diskriminacijo, kjer se lahko posamezniki soočajo s predsodki na podlagi njihovih genetskih informacij. Ta skrb je še posebej pomembna v okviru zavarovanja in zaposlovanja, kjer bi bilo mogoče zlorabiti genetske podatke.

Ključna vprašanja sta tudi zasebnost in varnost podatkov. Ker genetske informacije postanejo del zdravstvenih kartotek, je zagotovilo, da je njegova zaščita pred nepooblaščenim dostopom najpomembnejša. Izvajalci zdravstvenih storitev se morajo držati strogih protokolov varstva podatkov in izobraževati paciente o pomenu teh ukrepov.

Poleg tega potencial za prekomerno odvisnost od genetskih podatkov predstavlja tveganja. Medtem ko ima genetika ključno vlogo pri odzivanju na zdravila, niso edini determinanti. Okoljski dejavniki, izbira življenjskega sloga in druga zdravstvena stanja vplivajo tudi na rezultate zdravljenja. Ključnega pomena je, da izvajalci zdravstvenih storitev ohranjajo celostni pristop in vključujejo genetske vpoglede z drugimi ustreznimi zdravstvenimi informacijami.

Napredek v genetskih raziskavah in starejših odraslih

Nedavni napredek v genetskih raziskavah še naprej izboljšuje naše razumevanje, kako geni vplivajo na presnovo in odziv zdravil pri starejših odraslih. Razvoj celovitih genetskih baz podatkov in izboljšanih tehnologij testiranja je farmakogenomsko testiranje omogočil bolj dostopno in natančno.

Nastajajoče raziskave raziskujejo tudi potencial za ocene poligenih tveganj, ki ocenjujejo kumulativni učinek več genetskih različic na odziv na zdravila. Ti rezultati bi lahko zagotovili bolj zatemnjeno razumevanje posameznikove genetske nagnjenosti k določenim učinkom zdravil, kar bi utiralo pot natančnejšim in učinkovitejšim načrtom zdravljenja.

Poleg tega namen tekočih študij vključiti bolj raznolike populacije v genetske raziskave. V preteklosti so se genetske študije pretežno osredotočale na posameznike evropskega porekla, kar omejuje uporabnost ugotovitev na druge etnične skupine. Z razširitvijo obsega raziskav znanstveniki upajo, da bodo razvili bolj vključujoče in pravične strategije zdravljenja, ki skrbijo za gensko raznolikost globalne populacije.

Zaključek

Spremenljivost genetike in odziva ponujata obetavne možnosti za izboljšanje rezultatov zdravstvenega varstva pri starejših odraslih. Z izkoriščanjem genetskih vpogledov lahko prilagojena medicina optimizira učinkovitost in varnost zdravil, zlasti pri upravljanju zapletenih, kroničnih stanj. Vendar pa je za integracijo genetike v rutinsko zdravstveno prakso potrebno natančno upoštevati etične, praktične in finančne dejavnike. Ko raziskave napredujejo in se pojavljajo bolj vključujoče študije, postane potencial za personalizirano zdravilo preoblikovanje zdravstvenega varstva za starejše odrasle vse bolj dosegljivo.

Pogosta vprašanja

Kaj je farmakogenomika in kako lahko koristi starejšim odraslim?

Farmakogenomika je študija, kako geni vplivajo na odziv posameznika na zdravila. Starejšim odraslim lahko koristi tako, da prepozna genetske variacije, ki vplivajo.

Ali obstajajo tveganja, povezana z genetskim testiranjem pri starejših odraslih?

Da, genetsko testiranje ima tveganja, kot so pomisleki glede zasebnosti, potencialna diskriminacija in psihološki vpliv rezultatov testov. Ključnega pomena je zagotoviti informirano soglasje in trdne ukrepe za varstvo podatkov, ki bodo ublažili ta tveganja.

Kako se lahko personalizirano zdravilo spopada z izzivi polifarmacije pri starejših odraslih?

Prilagojena medicina lahko pomaga pri upravljanju polifarmacije z uporabo genetskih informacij za določitev najprimernejših zdravil in odmerkov za posameznika, kar zmanjša tveganje za interakcije z zdravili in neželene učinke, ki so pogosti pri starejših odraslih, ki jemljejo več zdravil.

Leave a Comment

Your email address will not be published. Required fields are marked *